Sodium and potassium disturbances in the elderly: Prevalence and association with drug use

Clinical Drug Investigation

Volumn 24, Issue 9, 2004, Pages 535-544

  Passare, Galina ^a   Viitanen, Matti ^a,b   Törring, Ove ^a   Winblad, Bengt ^a   Fastbom, Johan ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF TURKU   (Finland)

^c AGING RESEARCH CENTER   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTACID AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIINFECTIVE AGENT; ANXIOLYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CARBAMAZEPINE; CARDIAC GLYCOSIDE; CLOFIBRATE; CORTICOSTEROID; CYANOCOBALAMIN; CYTOSTATIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENEMA; HYPNOTIC SEDATIVE AGENT; LAXATIVE; LEVODOPA; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OSMOTIC AGENT; POTASSIUM; POTASSIUM SPARING DIURETIC AGENT; SODIUM; THIAZIDE DIURETIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

AGED; ARTICLE; DRUG USE; FEMALE; GENDER; GERIATRIC CARE; HIGH RISK POPULATION; HUMAN; HYPERKALEMIA; HYPERNATREMIA; HYPOKALEMIA; HYPONATREMIA; INCIDENCE; INSTITUTIONAL CARE; INTERVIEW; MAJOR CLINICAL STUDY; MALE; POTASSIUM BLOOD LEVEL; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SODIUM BLOOD LEVEL; SWEDEN;

EID: 4644318401     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-200424090-00004     Document Type: Article

References (54)

1. Adams KR, Martin JA. Electrolyte disorders in the elderly. Drugs Aging 1991; 1: 254-65
2. Gennari FJ. Hypokalemia. N Engl J Med 1998; 339: 451-8
3. Schwab M, Röder F, Mörike K, et al. Drug-induced hyponatremia in elderly patients. Br J Clin Pharmacol 1999; 48: 105-6
4. Anderson RJ, Chung H-M, Kluge R, et al. Hyponatremia: a prospective analysis of its epidemiology and the pathogenic role of vasopressin. Ann Intern Med 1985; 102: 164-8
5. Miller M. Disorders of water and sodium balance. In: Abrams WB, Berkow R, editors. The Merck manual of geriatrics. Rahway (NJ): Merck Sharp & Dohme Research Laboratories, 1990: 24-35
6. Adrogue HJ, Madias NE. Hypernatremia. N Engl J Med 2000; 342: 1493-9
7. Isaac G, Holland O. Drug-induced hypokalaemia. A cause for concern. Drugs Aging 1992; 2: 35-41
8. Walmsley RN, White GH, Cain M, et al. Hyperkalemia in the elderly. Clin Chem 1984; 30: 1409-12
9. Long CA, Marin P, Bayer AG, et al. Hypernatremia in an adult in-patient population. Postgrad Med J 1991; 67: 643-5
10. Snyder A, Feigal DW, Arieff AL. Hypernatremia in elderly patients: a heterogeneous, morbid, and iatrogenic entity. Ann Intern Med 1987; 107: 309-19
11. Mahowald JM, Himmelstein DU. Hypernatremia in the elderly: relation to infection and mortality. J Am Geriatr Soc 1981; 29: 177-80
12. Palevsky PM, Bhaagrath R, Greenberg A. Hypernatremia in hospitalized patients. Ann Intern Med 1996; 124: 197-203
13. Gabow PA. Peterson LN. Disorders of potassium metabolism. In: Schrier RW, editor. Renal and electrolyte disorders. 4th ed. Boston (MA): Little, Brown and Company, 1992: 231-87
14. Feinfeld DA, Carvounis CP. Fatal hyperkalemia and hyperchloremic acidosis: association with spironolactone in the absence of renal impairment. JAMA 1978; 240: 1516
15. Brass EP, Leigh-Thompson W. Drug-induced electrolyte abnormalities. Drugs 1982; 24: 207-28
16. Rondanelli M, Solere SB, Ferrari E. Electrolytes and cognitive function in the elderly: relationship between serum sodium and chloride concentrations and psychometric test scores. Panminerva Med 1998; 40: 191-5
17. Swaminathan R. Disorders of metabolism 2. In: Davies DM, editor. Textbook of adverse drug reactions. Oxford: Oxford University Press, 1991: 399-451
18. Perazella MA, Mahnensmith RL. Hyperkalemia in the elderly: drugs exacerbate impaired potassium homeostasis. J Gen Intern Med 1997; 12: 646-56
19. Ponce SP, Jennings AE, Madias NE, et al. Drug-induced hyperkalemia. Medicine (Baltimore) 1985; 64: 357-70
20. Cannon-Babb M, Schwartz AB. Drug-induced hyperkalemia. Hosp Pract 1986; 21: 99-107, 111, 114-27
21. Fratiglioni L, Viitanen M, Bäckman L, et al. Occurrence of dementia in advanced age: the study design of the Kungsholmen project. Neuroepidemiology 1992; 11: 29-36
22. Lindberg J, Claesson CB, Cornelius C, et al. Medicine use in the elderly: a population study in an urban area of Sweden. Drug Invest 1994; 8: 241-53
23. WHO. Guidelines for ATC classification. Oslo. WHO Collaborating centre for Drug Statistics and Methodology, 1990
24. Abrams W, Berkow R, editors. The Merck manual of geriatrics. New Jersey (NY): Merck Sharpe & Dohme, 1990
25. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41
26. Sunderam SG, Mankikar GD. Hyponatraemia in the elderly. Age Ageing 1983; 12: 77-80
27. Sharma H, Pompei P. Antidepressant-induced hyponatraemia in the aged. Drugs Aging 1996; 8: 430-5
28. Arieff AI. Management of hyponatraemia. BMJ 1993; 307: 305-8
29. Juul Sorensen I, Matzen LE. Serumelektrolytter og medikamentel behandling hos patienter indlagt på en geriatrisk afdelning. Ugeskr Laeger 1993; 155: 3921-4
30. Sharabi Y, Illan R, Kamari Y, et al. Diuretic induced hyponatremia in elderly hypertensive women. J Hum Hypertens 2002; 16: 631-5
31. Nicholls MG, Espiner EA, Ikram H, et al. Hyponatraemia in congestive heart failure during treatment with captopril. BMJ 1980; 281 (6245): 909
32. Cesar KR, Magaldi AJ. Thiazide induces water absorption in the inner medullary collecting duct of normal and Brattleboro rats. Am J Physiol 1999; 277: F756-60
33. Henry DA, Lawson DH, Reavey P, et al. Hyponatraemia during carbamazepine treatment. BMJ 1977; 1: 83-4
34. Lahr MB. Hyponatremia during carbamazepine therapy. Clin Pharmacol Ther 1985; 37: 693-6
35. Yassa R, Iskandar H, Nastase C, et al. Carbamazepine and hyponatremia in patients with affective disorder. Am J Psychiatry 1988; 145: 339-42
36. Gandelman MS. Review of carbamazepine-induced hyponatremia. Prog Neuropsychopharmacol Biol Psychiatry 1994; 18: 211-33
37. Nielsen OA, Johannessen AC, Bardrum B. Oxycarbazepine-induced hyponatremia, a cross sectional study. Epilepsy Res 1988; 2: 269-71
38. Sordillo P, Sagransky DM, Mercado R, et al. Carbamazepine-induced syndrome of inappropriate antidiuretic hormone secretion. Arch Intern Med 1978; 138: 299-301
39. Smith NJ, Espir MLE. Raised plasma arginine vasopressin concentration in carbamazepine-induced water intoxication. BMJ 1977; 2 (6090): 804
40. Kimura T, Matsui K, Sato T, et al. Mechanism of carbamazepine (Tegretol)-induced antidiuresis: evidence for release of antidiuretic hormone and impaired excretion of a water load. J Clin Endocrinol Metab 1974; 38: 356-62
41. Rosholm J-U, Nybo H, Andersen Ranberg K, et al. Hyponatremia in very old nonhospitalised people. Drugs Aging 2002; 19: 685-93
42. Nanji AA, Lauener RW. Lactulose-induced hypematremia. Drug Intell Clin Pharm 1984; 18: 70-1
43. Paice BJ, Paterson KR, Onyanga-Omara F, et al. Record linkage study of hypokalaemia in hospitalized patients. Postgrad Med J 1986; 62: 187-91
44. Knochel JP. Diuretic-induced hypokalemia. Am J Med 1984; 77: 18-27
45. Lowe J, Gray J, Henry DA, et al. Adverse reactions to frusemide in hospital inpatients. BMJ 1979; 2: 360-2
46. Gifford RW. A guide to the practical use of diuretics. JAMA 1976; 235: 1890-3
47. Udezue EO, Harrold BP. Hyperkalaemic paralysis due to spironolactone. Postgrad Med J 1980; 56: 254-5
48. Greenblatt DJ, Koch-Weser J. Adverse reactions to spironolactone. JAMA 1973; 225: 40-3
49. Whiting FM, McLaran CJ, Bochner F. Severe hyperkalaemia with Moduretic. Med J Aust 1979; 1 (9): 409
50. Berglund G, Andersson O, Larsson O, et al. Antihypertensive effect and side-effects of bendroflumethiazide and propranolol. Acta Med Scand 1976; 199: 499-506
51. Brecht HM, Werner E, Schoeppe W. Increase of total body potassium and decrease of exchangeable sodium after long-term treatment with a β-receptor-blocking agent (prindolol) in essential hypertension. Clin Sci Mol Med Suppl 1976; 3: 551S-4S
52. Guo Z, Fratiglioni L, Winblad B, et al. Blood pressure and performance on the Mini-Mental State Examination in the very old: cross-sectional and longitudinal data from the Kungsholmen Project. Am J Epidemiol 1997; 145: 1106-13
53. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998; 98: 2282-9
54. Giron M-ST, Claesson C, Thorslund M, et al. Drug use patterns in a very elderly population: a seven-year review. Clin Drug Invest 1999; 17: 389-98